Lorin Randall, Director at ACORDA THERAPEUTICS INC (ACOR), sold 2,500 shares at $31.60 ($79K) on 2011-05-20, disclosed to the SEC on 2011-05-23.
Scheduled sale ($79k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2016-04-21 | $43K | — | Filing → |
| ATHX | SELL | 2014-08-19 | $23K | — | Filing → |
| TNGN | SELL | 2013-09-06 | $239 | — | Filing → |